首页> 外国专利> METHOD OF OBTAINING IMMUNOGENIC NON-HEMOLYTHIC BACTERIUM OF SPECIES Actinobacillus pleuropneumoniae, BACTERIUM OF SPECIES Actinobacillus pleuropneumoniae, VACCINE AGAINST PIG PLEUROPNEUMONIA (VERSIONS), IMMUNOGENIC AND NON-HAEMOLYTIC STRAIN OF Actinobacillus pleuropneumoniae (VERSIONS)

METHOD OF OBTAINING IMMUNOGENIC NON-HEMOLYTHIC BACTERIUM OF SPECIES Actinobacillus pleuropneumoniae, BACTERIUM OF SPECIES Actinobacillus pleuropneumoniae, VACCINE AGAINST PIG PLEUROPNEUMONIA (VERSIONS), IMMUNOGENIC AND NON-HAEMOLYTIC STRAIN OF Actinobacillus pleuropneumoniae (VERSIONS)

机译:获得胸膜肺炎放线杆菌的免疫原性非嗜血菌的方法,胸膜肺炎放线杆菌的细菌,针对猪肺炎肺炎的疫苗(版本),免疫原性和非嗜血性肺炎的菌株

摘要

FIELD: biotechnologies.;SUBSTANCE: invention relates to field of biotechnology, namely to obtaining vaccine strains, and can be used in veterinary. Bacterium Actinobacillus pleuropneumoniae is modified by introducing deletion, of at least one segment of gene apxIA and, optionally, segment of gene apxIIA, which code transmembrane domain of haemolytic and cytolytic exotoxins Apx. Obtained bacterium is used for production of vaccine against pig pleuropneumonia.;EFFECT: invention allows obtaining attenuated live vaccine against pig pleuropneumonia based on immunogenic non-haemolytic strain of bacterium Actinobacillus pleuropneumoniae.;11 cl, 6 dwg, 3 tbl, 1 ex
机译:疫苗技术领域本发明涉及生物技术领域,即获得疫苗株,并且可以在兽医学中使用。胸膜肺炎放线杆菌细菌是通过引入至少一个基因apxIA区段和任选地基因apxIIA区段的缺失来修饰的,所述基因编码溶血性和细胞溶性外毒素Apx的跨膜结构域。获得的细菌用于生产猪胸膜肺炎疫苗。效果:本发明允许基于猪胸膜肺炎放线杆菌的免疫原性非溶血菌株获得减毒猪胸膜肺炎活疫苗。11cl,6 dwg,3 tbl,1 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号